These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
424 related articles for article (PubMed ID: 20056918)
1. Angiotensin II inhibits neuronal nitric oxide synthase activation through the ERK1/2-RSK signaling pathway to modulate central control of blood pressure. Cheng WH; Lu PJ; Ho WY; Tung CS; Cheng PW; Hsiao M; Tseng CJ Circ Res; 2010 Mar; 106(4):788-95. PubMed ID: 20056918 [TBL] [Abstract][Full Text] [Related]
2. Angiotensin II inhibits DDAH1-nNOS signaling via AT1R and μOR dimerization to modulate blood pressure control in the central nervous system. Sun GC; Wong TY; Chen HH; Ho CY; Yeh TC; Ho WY; Tseng CJ; Cheng PW Clin Sci (Lond); 2019 Dec; 133(23):2401-2413. PubMed ID: 31755934 [TBL] [Abstract][Full Text] [Related]
3. Simvastatin induces a central hypotensive effect via Ras-mediated signalling to cause eNOS up-regulation. Cheng WH; Ho WY; Chang CF; Lu PJ; Cheng PW; Yeh TC; Hong LZ; Sun GC; Hsiao M; Tseng CJ Br J Pharmacol; 2013 Oct; 170(4):847-58. PubMed ID: 23889671 [TBL] [Abstract][Full Text] [Related]
4. Resveratrol regulates blood pressure by enhancing AMPK signaling to downregulate a Rac1-derived NADPH oxidase in the central nervous system. Yeh TC; Shin CS; Chen HH; Lai CC; Sun GC; Tseng CJ; Cheng PW J Appl Physiol (1985); 2018 Jul; 125(1):40-48. PubMed ID: 29494287 [TBL] [Abstract][Full Text] [Related]
5. Involvement of endogenous nitric oxide in angiotensin II-induced activation of vascular mitogen-activated protein kinases. Zhang GX; Nagai Y; Nakagawa T; Miyanaka H; Fujisawa Y; Nishiyama A; Izuishi K; Ohmori K; Kimura S Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2403-8. PubMed ID: 17616751 [TBL] [Abstract][Full Text] [Related]
6. Shift to an involvement of phosphatidylinositol 3-kinase in angiotensin II actions on nucleus tractus solitarii neurons of the spontaneously hypertensive rat. Sun C; Zubcevic J; Polson JW; Potts JT; Diez-Freire C; Zhang Q; Paton JF; Raizada MK Circ Res; 2009 Dec; 105(12):1248-55. PubMed ID: 19850939 [TBL] [Abstract][Full Text] [Related]
7. Loss of biphasic effect on Na/K-ATPase activity by angiotensin II involves defective angiotensin type 1 receptor-nitric oxide signaling. Banday AA; Lokhandwala MF Hypertension; 2008 Dec; 52(6):1099-105. PubMed ID: 18955661 [TBL] [Abstract][Full Text] [Related]
8. Different protective actions of losartan and tempol on the renal inflammatory response to acute sodium overload. Rosón MI; Della Penna SL; Cao G; Gorzalczany S; Pandolfo M; Toblli JE; Fernández BE J Cell Physiol; 2010 Jul; 224(1):41-8. PubMed ID: 20232302 [TBL] [Abstract][Full Text] [Related]
9. The PI3K signaling-mediated nitric oxide contributes to cardiovascular effects of angiotensin-(1-7) in the nucleus tractus solitarii of rats. Wu ZT; Ren CZ; Yang YH; Zhang RW; Sun JC; Wang YK; Su DF; Wang WZ Nitric Oxide; 2016 Jan; 52():56-65. PubMed ID: 26686278 [TBL] [Abstract][Full Text] [Related]
10. Fructose induced neurogenic hypertension mediated by overactivation of p38 MAPK to impair insulin signaling transduction caused central insulin resistance. Cheng PW; Lin YT; Ho WY; Lu PJ; Chen HH; Lai CC; Sun GC; Yeh TC; Hsiao M; Tseng CJ; Liu CP Free Radic Biol Med; 2017 Nov; 112():298-307. PubMed ID: 28754499 [TBL] [Abstract][Full Text] [Related]
11. Role of angiotensin II and oxidative stress in vascular insulin resistance linked to hypertension. Zhou MS; Schulman IH; Raij L Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H833-9. PubMed ID: 19151253 [TBL] [Abstract][Full Text] [Related]
12. Role of angiotensin II and free radicals in blood pressure regulation in a rat model of renal hypertension. Dobrian AD; Schriver SD; Prewitt RL Hypertension; 2001 Sep; 38(3):361-6. PubMed ID: 11566905 [TBL] [Abstract][Full Text] [Related]
13. Administration of telmisartan reduced systolic blood pressure and oxidative stress probably through the activation of PI3K/Akt/eNOS pathway and NO release in spontaneously hypertensive rats. Xu L; Liu Y Physiol Res; 2013; 62(4):351-9. PubMed ID: 23590610 [TBL] [Abstract][Full Text] [Related]
14. ERK activation contributes to regulation of spontaneous contractile tone via superoxide anion in isolated rat aorta of angiotensin II-induced hypertension. Ding L; Chapman A; Boyd R; Wang HD Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2997-3005. PubMed ID: 17308007 [TBL] [Abstract][Full Text] [Related]
15. Synergistic actions of enalapril and tempol during chronic angiotensin II-induced hypertension. Elmarakby AA; Williams JM; Imig JD; Pollock JS; Pollock DM Vascul Pharmacol; 2007 Feb; 46(2):144-51. PubMed ID: 17112788 [TBL] [Abstract][Full Text] [Related]
17. Losartan and tempol treatments normalize the increased response to hydrogen peroxide in resistance arteries from hypertensive rats. García-Redondo AB; Briones AM; Avendaño MS; Hernanz R; Alonso MJ; Salaices M J Hypertens; 2009 Sep; 27(9):1814-22. PubMed ID: 19491705 [TBL] [Abstract][Full Text] [Related]
18. Adenosine modulates cardiovascular functions through activation of extracellular signal-regulated kinases 1 and 2 and endothelial nitric oxide synthase in the nucleus tractus solitarii of rats. Ho WY; Lu PJ; Hsiao M; Hwang HR; Tseng YC; Yen MH; Tseng CJ Circulation; 2008 Feb; 117(6):773-80. PubMed ID: 18227383 [TBL] [Abstract][Full Text] [Related]
19. Angiotensin II type 2 receptor-dependent increase in nitric oxide synthase activity in the endothelium of db/db mice is mediated via a MEK pathway. Taguchi K; Matsumoto T; Kamata K; Kobayashi T Pharmacol Res; 2012 Jul; 66(1):41-50. PubMed ID: 22465219 [TBL] [Abstract][Full Text] [Related]
20. Effects of an ARB on endothelial progenitor cell function and cardiovascular oxidation in hypertension. Yu Y; Fukuda N; Yao EH; Matsumoto T; Kobayashi N; Suzuki R; Tahira Y; Ueno T; Matsumoto K Am J Hypertens; 2008 Jan; 21(1):72-7. PubMed ID: 18091747 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]